Small Molecules
16 April 2018
Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting12 April 2018
Cirius Therapeutics’ Preclinical Data Demonstrates Potential for Lead Drug Candidate MSDC-0602K in NASH12 April 2018
Adynxx Announces Results of the ADYX-004 Phase 2 Study of Brivoligide (AYX1) for the Treatment of Post-Surgical Pain11 April 2018
New compound could improve stroke patient recovery11 April 2018
Novartis drug Afinitor DISPERZ® receives FDA approval to treat TSC-associated partial-onset seizure10 April 2018
Therapix Biosciences Announces Topline Results of Phase IIa Study at Yale University for Tourette Syndrome Program9 April 2018
Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder9 April 2018
Ionis and AstraZeneca Advance New Drug for NASHNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports